
The Prognostic Significance and Co-Expression of Fibroblast Growth Factor Receptor 2 and c-Met in Endometrial Cancer
Introduction Endometrial cancer (EC) is one of the most common gynecologic malignancies, and its incidence is increasing. In the United States, 61380 estimated new cases of EC and 10920 estimated EC-related deaths are expected in 2017.1 Most EC patients …